Analyse court terme - JOHNSON & JOHNSON : Le MACD a croisé en hausse.
La tendance est toujours neutre. Il faut franchir le sommet à 135,000 $ pour que la tendance devienne positive avec une invalidation sous 128,200 $.Arguments :
- Le support a été enfoncé, mais il est réintégré. Les prix peuvent rebondir.
- Les cours font un pull-back sur la résistance majeure (ancien support), la baisse reprendra ensuite.
- Le MACD a croisé en hausse.
- Les prix enfoncent la moyenne mobile.
Johnson & Johnson is a holding company engaged in the research and development, manufacture and sale of a range of products in the health care field. The company has three business segments: Consumer, which includes a range of products focused on personal healthcare used in the beauty, over-the-counter pharmaceutical, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension; and Medical Devices, which includes products used in the orthopaedic, surgery, interventional solutions, and eye health fields.
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.